From Spectra to Structure: An Interview with Novogaia’s Tess Bevers - Takeaway - MDSpire
Feature

From Spectra to Structure: An Interview with Novogaia’s Tess Bevers

Novogaia’s transformer-based model converts untargeted mass spectra into structural predictions for early-stage drug discovery

Share

  • 1

    Gaia-01 predicts molecular structures from mass spectrometry data.

  • 2

    Fungi are chosen for drug discovery due to genetic similarities to humans.

  • 3

    The model's performance is benchmarked using MassSpecGym.

  • 4

    Gaia-01 achieved a notable jump in prediction accuracy to 41%.

  • 5

    The project aims at continuous feedback for improved data processing.

Original Source(s)

From Spectra to Structure: An Interview with Novogaia’s Tess Bevers

  • by Henry Thomas

  • April 15, 2026

Related Content

Is Standard of Care Optimal for the Individual Patient?

I am writing this from the hospital waiting room. My father is undergoing an 11-hour surgery to remove his parotid gland and a squamous cell carcinoma that has metastasized from his cheek and invaded ...

Mass Spec Roundup: From Masterpieces to Microplastics

Advances in imaging, AI, and single-cell analysis reveal hidden chemistry in art, biology, and the environment

  • April 15, 2026

  • 6 min
Cell and Gene Roundup: CAR T Breaks New Ground

A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression

  • April 15, 2026

  • 6 min